Reframe Cancer has appointed Russell Young to the newly created role of commercial director.
Young (pictured) joins from Further Group UK where he was director of sales and account management and worked with insurers and brokers on international navigation and support of cancer.
He has also held roles at Cigna Europe as corporate sales consultant and at Morgan Price International Healthcare where he was a business development manager.
He will head up Reframe’s sales function and join the senior management team reporting to CEO Mark Stephenson.
Young said: “I’m delighted to be joining Reframe Cancer at a time when they are going through significant growth.
“What they do for cancer patients is amazing and I look forward to working with insurers, employers and intermediaries to help bring their proven solutions to as many employees and individuals as possible.”
Stephenson added: “We’re so pleased to have secured Russell to head up our commercial function.
“His appointment will help bring innovative solutions across the whole cancer pathway and help us further expand in our designated customer channels.
“His knowledge of the market mixed with his ethical approach will further help us grow as we continue to expand and invest in new systems.”
Young’s appointment follows April’s hire of professor Ben Kelly from Nuffield Health as chief operating officer and last month’s appointment of Nikki Cannon who previously led the transformation of personalised care and survivorship at Guy’s and St. Thomas’ NHS Trust, as head of screening.
